Skip to main content
Signal8

Goldberg Mark Alan

SEC insider (Form 3/4/5 filer). CIK 0001532475. Director at Blueprint Medicines Corp (BPMC). 3 reported Form 4/5 transactions since Sep 2024; latest on Jul 17, 2025. Located in CAMBRIDGE, MA.

Companies Goldberg Mark Alan has filed insider reports for

  • Blueprint Medicines Corp (BPMC): Director
Goldberg Mark Alan profile photo

Goldberg Mark Alan

CIK: 0001532475

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)2 (66.7%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Blueprint Medicines Corp logo
BPMC

Blueprint Medicines Corp

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • Blueprint Medicines Corp logo
    BPMC

    Blueprint Medicines Corp

    Jul 17, 2025
    Disposition
    Direct
    3.9K shares-
  • Blueprint Medicines Corp logo
    BPMC

    Blueprint Medicines Corp

    Jul 17, 2025
    Tender Offer
    Direct
    18.3K shares-
  • Blueprint Medicines Corp logo
    BPMC

    Blueprint Medicines Corp

    Jun 18, 2025
    Award
    Direct
    3.9K shares at avg. $128.12$500K

1-3 of 3